Stock Quote. NASDAQ: PCRXData as of 04/23/24 4:00 pm EDT. 26.81USD+ 0.71 (+2.72%). Volume | 497,169. Data Provided by Refinitiv. Minimum 15 minutes delayed ...
... Investors · Overview · Events · SEC Filings · Analyst Coverage · Corporate Governance · Investor FAQs · Sustainability · Careers · Life at Pacira · Join Our ...
People also ask
What company makes Exparel?
Who bought Flexion Therapeutics?
Is Pacira a pharmaceutical company?
What is the mission statement of Pacira?
According to Zacks Investment Research, based on 7 analysts' forecasts, the consensus EPS forecast for the quarter is $0.46. The reported EPS for the same ...
May 18, 2023 · Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects.
Missing: relations | Show results with:relations
(Nasdaq: PCRX), the industry leader in its ... The company is also providing weekly EXPAREL utilization and elective surgery data within its investor presentation ...
NASDAQ INVESTOR RELATIONS · News & Events RELEASES & PRESENTATIONS · Stock STOCK QUOTE & MORE · Financials QUARTERLY RESULTS & MORE · ESG · Governance CORPORATE ...
Find the latest Pacira BioSciences, Inc. (PCRX) stock quote, history, news and other vital information to help you with your stock trading and investing.
Missing: investor relations